-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Kiora Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to Q3 2025.
- Kiora Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was -$643K.
- Kiora Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $1.43M.
- Kiora Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2024 was $2.07M, a 2186% increase from 2023.
- Kiora Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $90.3K.
- Kiora Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was -$113K, a 41.3% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)